Please provide your email address to receive an email when new articles are posted on . The photopneumatic device improved acne in 66.7% of patients in this 7-week trial. Improvements were seen across ...
Denifanstat met all endpoints in a Phase 3 acne trial and showed favorable tolerability. Sagimet also launched a Phase 1 trial for TVB-3567. Sagimet Biosciences announced that its oral fatty acid ...
Please provide your email address to receive an email when new articles are posted on . Denifanstat, a fatty acid synthase inhibitor, was effective in the treatment of moderate to severe acne vulgaris ...
Final patient visit marks key milestone for Biofrontera, with top-line results expected Q1 2026 Company plans FDA discussion in Q3 2026 to advance Phase 3 program and potential label expansion More ...
Following a Mediterranean diet and taking an over-the-counter supplement can help reduce acne and improve quality of life, a new study shows. The research, published Wednesday in the Journal of ...
Add Yahoo as a preferred source to see more of our stories on Google. When you buy through links on our articles, Future and its syndication partners may earn a commission. In a clinical trial, ...
The treatment of acne ( Table I) [1,2,3,4,5,6] is based upon its severity (mild, moderate, severe) and the type(s) of lesion(s) present (noninflammatory, inflammatory, mixed). In general, the ...
Sagimet Biosciences shares rose after the company said it would focus on advancing development of its acne treatment in the U.S. The stock climbed 29% to $7.55 in premarket trading Monday. Through ...
Acne remains a very common inflammatory dermatosis, which is often associated with significant psychological morbidity. It frequently affects young adults at a time when they are undergoing maximal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results